Abiopharma

🔍 Wellborn Gayle Furgurson (Executive)

Company: HEALTHEQUITY, INC. (HQY)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 2,877 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 22,610.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the earlier of; (i) June 25, 2027, or (ii) the date of the issuer's next annual stockholder meeting in June 2027. Vested shares will be delivered to the reporting person upon vesting.
• REMARKS: The Power of Attorney given by Ms. Wellborn was previously filed with the U.S. Securities and Exchange Commission on June 26, 2023, as an exhibit to a statement on Form 4 filed by Ms. Wellborn with respect to HealthEquity, Inc. and is hereby incorporated by reference.